MENU
NXTC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
NextCure (NXTC) Ownership - Who owns NextCure?
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
9000 Virginia Manor Road
Phone
+1 240 399-4900
Employees
82
Web
https://www.nextcure.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.18M
P/E Ratio
N/A
Total Cash
55.86M
Projected Growth
N/A
Total Debt
4.91M
Revenue
N/A
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash/Share
1.99
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NXTC
Capitalization
13.2M
P/E Ratio
N/A
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash
55.9M
Total Cash/Share
1.99
Total Debt
4.91M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
55.9M
P/B Ratio
0.24
Cash Flow
N/A
Earnings
-1.77
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
28K
Current Ratio
10.26
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-50.34M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-54.33
Shares Held By Institutions
8.91M
Shares Outstanding - Current
28.1M
Total Liabilities
11.3M
Total Volume MTD
N/A
Value
1
Gain YTD
-41.634
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
9000 Virginia Manor Road
Phone
+1 240 399-4900
Employees
82
Web
https://www.nextcure.com